Drug Type Small molecule drug |
Synonyms TRIAMINIC-12 |
Mechanism ADRA1 agonists(Adrenergic receptor alpha-1 agonists), D1 receptor partial agonists(Dopamine D1 receptor partial agonists), H1 receptor antagonists(Histamine H1 receptor antagonists) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseWithdrawn |
First Approval Date US (01 Jan 1982) |
Regulation- |
Molecular FormulaC20H23ClN2O4 |
InChIKeyDBAKFASWICGISY-BTJKTKAUSA-N |
CAS Registry113-92-8 |